EDWARD GREISSING jr

All provisions of HR 1919 "Safeguarding America's Pharmaceutical SAct of 2013" and all provisions of S 957 "Drug Supply Chain Security Act"

All provisions of HR 1919 "Safeguarding America's Pharmaceutical SAct of 2013" and all provisions of S 957 "Drug Supply Chain Security Act"

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

Education and awareness of the 2013-2014 influenza season; education and awareness of pandemic and biodefense funding, including policy ramifications of recent BARDA contract awards; education and awareness of dengue; general issues related to FDA funding; general issues related to NIH funding; general issues related to diabetes awareness; all provisions of HR 2094 "School Access to Emergency Epinephrine Act"; and issues related to the continued over-the-counter availability of allergy, cough and coldmedicines that contain pseudoephedrine

general issues related to corporate income tax reform; a strengthened and permanent U.S. R&D tax credit; extending and maintaining the orphan drug tax credit; all provisions of HR 2835 "Restoring Access to Medication Act of 2013"

International intellectual property issues; and all provisions of HR 2985 "Combination Drug Development Incentive Act of 2013".

All provisions of HR 3204 "Drug Quality and Security Act"

Education and awareness regarding illegal compounding of veterinary drugs for animals; general issues related to the reauthorization of the Animal Drug User Fee Act; HR1150 "Preservation of Antibiotics for Medical Treatment Act of 2013"; HR820 "Delivering Antimicrobial Transparency in Animals Act of 2013."

Education and awareness regarding illegal compounding of veterinary drugs for animals; general issues related to the reauthorization of the Animal Drug User Fee Act; HR1150 "Preservation of Antibiotics for Medical Treatment Act of 2013"; HR820 "Delivering Antimicrobial Transparency in Animals Act of 2013."

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

S. 77 "Prescription Drug and Health Improvement Act of 2013" - all provisions; S117, "Medicare Prescription Drug Price Negotiation Act of 2013" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; reauthorization of Pandemic and All HazardsPreparation Act; general issues related to the importation of pharmaceutical products; issues related to chronic disease treatment adherence with the CMS Innovation Center; general issues related to School Access to Emergency Ephinephrine; and issues related to the data exclusivity period for generic biologics.

S. 77 "Prescription Drug and Health Improvement Act of 2013" - all provisions; S117, "Medicare Prescription Drug Price Negotiation Act of 2013" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; reauthorization of Pandemic and All HazardsPreparation Act; general issues related to the importation of pharmaceutical products; issues related to chronic disease treatment adherence with the CMS Innovation Center; general issues related to School Access to Emergency Ephinephrine; and issues related to the data exclusivity period for generic biologics.

Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; NIH funding; general issues related to diabetes awareness; all provisions of S 557 "Medication Therapy Management Empowerment Act of 2013"; all provisions of S 596 "Fostering Independence Through Technology Act of 2013"; issues related to the Independent Payment Advisory Board; general issues related to School Access to EmergencyEpinephrine; and issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine.

Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; NIH funding; general issues related to diabetes awareness; all provisions of S 557 "Medication Therapy Management Empowerment Act of 2013"; all provisions of S 596 "Fostering Independence Through Technology Act of 2013"; issues related to the Independent Payment Advisory Board; general issues related to School Access to EmergencyEpinephrine; and issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine.

Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; NIH funding; general issues related to diabetes awareness; all provisions of S 557 "Medication Therapy Management Empowerment Act of 2013"; all provisions of S 596 "Fostering Independence Through Technology Act of 2013"; issues related to the Independent Payment Advisory Board; general issues related to School Access to EmergencyEpinephrine; and issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine.

Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; NIH funding; general issues related to diabetes awareness; all provisions of S 557 "Medication Therapy Management Empowerment Act of 2013"; all provisions of S 596 "Fostering Independence Through Technology Act of 2013"; issues related to the Independent Payment Advisory Board; general issues related to School Access to EmergencyEpinephrine; and issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine.

Education and awareness of issues related to the compounding of medications for animal health, including all provisions of S 959 "Pharmaceutical Compounding Quality and Accountability Act"; all provisions of HR 1407 "Animal Drug User Fee Amendments of 2013" Education and awareness regarding illegal compounding of veterinary drugs for animals; all provisions of S 622 "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"

Education and awareness of issues related to the compounding of medications for animal health, including all provisions of S 959 "Pharmaceutical Compounding Quality and Accountability Act"; all provisions of HR 1407 "Animal Drug User Fee Amendments of 2013" Education and awareness regarding illegal compounding of veterinary drugs for animals; all provisions of S 622 "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"

S. 77 "Prescription Drug and Health Improvement Act of 2013" - all provisions; S117, "Medicare Prescription Drug Price Negotiation Act of 2013" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; reauthorization of Pandemic and All HazardsPreparation Act; general issues related to the importation of pharmaceutical products; issues related to chronic disease treatment adherence with the CMS Innovation Center; general issues related to School Access to Emergency Ephinephrine; and issues related to the data exclusivity period for generic biologics.

S. 77 "Prescription Drug and Health Improvement Act of 2013" - all provisions; S117, "Medicare Prescription Drug Price Negotiation Act of 2013" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; reauthorization of Pandemic and All HazardsPreparation Act; general issues related to the importation of pharmaceutical products; issues related to chronic disease treatment adherence with the CMS Innovation Center; general issues related to School Access to Emergency Ephinephrine; and issues related to the data exclusivity period for generic biologics.

All provisions of HR 1919 "Safeguarding America's Pharmaceutical SAct of 2013" and all provisions of S 957 "Drug Supply Chain Security Act"

All provisions of HR 1919 "Safeguarding America's Pharmaceutical SAct of 2013" and all provisions of S 957 "Drug Supply Chain Security Act"

Education and awareness of issues related to the compounding of medications for animal health, including all provisions of S 959 "Pharmaceutical Compounding Quality and Accountability Act"; all provisions of HR 1407 "Animal Drug User Fee Amendments of 2013" Education and awareness regarding illegal compounding of veterinary drugs for animals; all provisions of S 622 "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"

Education and awareness of issues related to the compounding of medications for animal health, including all provisions of S 959 "Pharmaceutical Compounding Quality and Accountability Act"; all provisions of HR 1407 "Animal Drug User Fee Amendments of 2013" Education and awareness regarding illegal compounding of veterinary drugs for animals; all provisions of S 622 "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"

Education and awareness of issues related to the compounding of medications for animal health, including all provisions of S 959 "Pharmaceutical Compounding Quality and Accountability Act"; and education and awareness regarding illegal compounding of veterinary drugs for animals.

S810 and HR1513 "Great Ape Protection and Cost Saving Act of 2011" - all provisions.

S810 and HR1513 "Great Ape Protection and Cost Saving Act of 2011" - all provisions.

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including the Independent Payment Advisory Board (IPAB); awareness & issues related to diabetes and patient access to diabetes care; general issues related to prescription drug safety; HR2529 "Restoring Access to Medication Act" - all provisions; HR2245 "Preserving Access to Life-Saving Medications Act of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of dengue; all provisions of S1002 "Safe Doses Act"; awareness & issues related to patient access to care for Dengue; and all provisions of draft legislation "Immunization Improvements Act of 2011."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act including issues related to the Independent Payment Advisory Board; "HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefense funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act including issues related to the Independent Payment Advisory Board; "HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation ActReauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefense funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues relatedto diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223 "SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue.

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including the Independent Payment Advisory Board (IPAB); awareness & issues related to diabetes and patient access to diabetes care; general issues related to prescription drug safety; HR2529 "Restoring Access to Medication Act" - all provisions; HR2245 "Preserving Access to Life-Saving Medications Act of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of dengue; all provisions of S1002 "Safe Doses Act"; awareness & issues related to patient access to care for Dengue; and all provisions of draft legislation "Immunization Improvements Act of 2011."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act including issues related to the Independent Payment Advisory Board; "HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation ActReauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefense funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including the Independent Payment Advisory Board (IPAB); awareness & issues related to diabetes and patient access to diabetes care; general issues related to prescription drug safety; HR2529 "Restoring Access to Medication Act" - all provisions; HR2245 "Preserving Access to Life-Saving Medications Act of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of dengue; all provisions of S1002 "Safe Doses Act"; awareness & issues related to patient access to care for Dengue; and all provisions of draft legislation "Immunization Improvements Act of 2011."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223 "SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues relatedto diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act including issues related to the Independent Payment Advisory Board; "HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefense funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.

S3239 and HR3798 "Egg Products Inspection Act Amendments of 2012" - all provisions; and issues related to a National Environmental Policy Act (NEPA) exclusion for veterinary biologics

S3239 and HR3798 "Egg Products Inspection Act Amendments of 2012" - all provisions; and issues related to a National Environmental Policy Act (NEPA) exclusion for veterinary biologics

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223 "SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues relatedto diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act including issues related to the Independent Payment Advisory Board; "HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation ActReauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefense funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act including issues related to the Independent Payment Advisory Board; "HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of pandemic and biodefense funding in FY2012 and related international intellectual property issues; and education and awareness of dengue.

Reauthorization of the Prescription Drug User Fee Act (PDUFA) including potential amendments and all provisions of HR5651 "Food and Drug Administration Reform Act of 2012" and S3187 "Food and Drug Administration Safety and Innovation Act"

General issues related to prescription drug supply chain, including importation safety, foreign inspections, track and trace, and drug shortage including related amendments to HR5651 "Food and Drug Administration Reform Act of 2012" and S3187 "Food and Drug Administration Safety and Innovation Act"

Reauthorization of the Prescription Drug User Fee Act (PDUFA) including potential amendments and all provisions of HR5651 "Food and Drug Administration Reform Act of 2012" and S3187 "Food and Drug Administration Safety and Innovation Act"

General issues related to prescription drug supply chain, including importation safety, foreign inspections, track and trace, and drug shortage, including related amendments to HR5651 "Food and Drug Administration Reform Act of 2012" and S3187 "Food and Drug Administration Safety and Innovation Act"

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

General issues related to foreign direct investment in the United States, including all provisions of S3274 and HR5910 "Global Investment in American Jobs Act of 2012"

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)", and HR8"American Taxpayer Relief Act of 2012"; adding Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program including such provisions in HR6687 and S3716 "To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the taxable vaccines.

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)", and HR8"American Taxpayer Relief Act of 2012"; adding Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program including such provisions in HR6687 and S3716 "To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the taxable vaccines.

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)", and HR8"American Taxpayer Relief Act of 2012"; adding Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program including such provisions in HR6687 and S3716 "To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the taxable vaccines.

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)", and HR8"American Taxpayer Relief Act of 2012"; adding Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program including such provisions in HR6687 and S3716 "To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the taxable vaccines.

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"; and efforts to add Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"; and efforts to add Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)", and HR8"American Taxpayer Relief Act of 2012"; adding Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program including such provisions in HR6687 and S3716 "To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the taxable vaccines.

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)", and HR8"American Taxpayer Relief Act of 2012"; adding Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program including such provisions in HR6687 and S3716 "To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the taxable vaccines.

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"; and efforts to add Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"; and efforts to add Quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223 "SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue.

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including the Independent Payment Advisory Board (IPAB); awareness & issues related to diabetes and patient access to diabetes care; general issues related to prescription drug safety; HR2529 "Restoring Access to Medication Act" - all provisions; HR2245 "Preserving Access to Life-Saving Medications Act of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of dengue; all provisions of S1002 "Safe Doses Act"; awareness & issues related to patient access to care for Dengue; and all provisions of draft legislation "Immunization Improvements Act of 2011."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223 "SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues relatedto diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues relatedto diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including issues related to the Independent Payment Advisory Board, and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; HR4223 "Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012" or "SAFE DOSES Act" - all provisions; issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue; and all provisions of H. Res. 295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease."

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223"SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues;education and awareness of dengue.

General issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" and efforts to repeal PL111-148 provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in HR2529 "Restoring Access to Medication Act" and HR436 "Health Care Cost Reduction Act of 2012"; awareness & issues related to diabetes and patient access to diabetes care; S1002 and HR4223 "SAFE DOSES Act" - all provisions; HR2405 and S1855 "Pandemic and All Hazards Preparation Act Reauthorization of 2011" - all provisions; HR3627 and S1884 "School Access to Emergency Epinephrine Act" - all provisions; education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues; education and awareness of dengue.

Comparative effectiveness, including issues related to the Patient Centered Research Insitute, issues related to limitations on the use of Health Savings Accounts for over-the-counter medicines, repeal and defunding efforts, & general issues regarding implementation of HR3590 "The Patient Protection and Affordable Care Act" including the Medication Therapy Management Program transitions of care; awareness and issues related to patient access to diabetes care; awareness and issues related to patient access to atrial fibrillation care; all provisions of S668 "Health Care Bureaucrats Elimination Act" and HR452 "Medicare Decisions Accountability Act of 2011"; issues related to importation of prescription medicines; issues related to efforts to move pseudoephedrine products to prescription drug status; section 401 of S174 "Healthy Lifestyles and Prevention (HeLP) America Act"; and issues related to pandemic influenza and biodefense funding

Comparative effectiveness, including issues related to the Patient Centered Research Insitute, issues related to limitations on the use of Health Savings Accounts for over-the-counter medicines, repeal and defunding efforts, & general issues regarding implementation of HR3590 "The Patient Protection and Affordable Care Act" including the Medication Therapy Management Program transitions of care; awareness and issues related to patient access to diabetes care; awareness and issues related to patient access to atrial fibrillation care; all provisions of S668 "Health Care Bureaucrats Elimination Act" and HR452 "Medicare Decisions Accountability Act of 2011"; issues related to importation of prescription medicines; issues related to efforts to move pseudoephedrine products to prescription drug status; section 401 of S174 "Healthy Lifestyles and Prevention (HeLP) America Act"; and issues related to pandemic influenza and biodefense funding

Provisions related to a mens rea requirement in HR675 "Strengthening Medicare Anti-Fraud Measures Act of 2011"

Extension of the U.S. R&D tax credit and all such provision in HR942 "The American Research and Competitiveness Act of 2011"

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011"

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"

Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011" and S1577 "Greater Research Opportunities With Tax Help Act (GROWTH Act)"

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including the Independent Payment Advisory Board (IPAB); awareness & issues related to diabetes and patient access to diabetes care; awareness & issues related to patient access to atrial fibrillation care, including all provisions in HRes295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease"; issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of dengue; general issues related to prescription drug safety and the importation of prescription drugs including amendment No. 769 to H.R. 2112 "Consolidated and Further Continuing Appropriations Act, 2012"; all provisions of S1002 "Safe Doses Act"; awareness & issues related to patient access to care for C. Difficile; awareness about the company's Access to Medicines Program; awareness & issues related to patient access to care for Dengue; and all provisions of draft legislation "Immunization Improvements Act of 2011."

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including all provisions of HR605 and S312 "Patients' Freedom to Choose Act," the Medication Therapy Management Program, transitions of care, and the Independent Payment Advisory Board (IPAB); awareness and issues related to patient access to diabetes care; awareness & issues related to patient access to atrial fibrillation care, including all provisions in HRes295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease", issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; intellectual propterty issues in the WHO global pandemic vaccine allocation plans; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of the company's global Access to Medicines Program; education and awareness of dengue; issues related to the Section 317 Program for vaccines; general issues related to prescription drug safety; and all provisions of S1002 "Safe Doses Act".

Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including all provisions of HR2529 "Restoring Access to Medication Act", the Medication Therapy Management Program, and the Independent Payment Advisory Board (IPAB); awareness and issues related to diabetes and patient access to diabetes care; awareness & issues related to patient access to atrial fibrillation care, including all provisions in HRes295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease", and S Res 243 "A resolution promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease"; issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; intellectual propterty issues in the WHO global pandemic vaccine allocation plans; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of dengue; general issues related to prescription drug safety and the importation of prescription drugs; and all provisions of S1002 "Safe Doses Act".